赛可沙尼-A对肥胖患者胰岛素抵抗的影响:计算和动物实验研究
Min-Seong Lee1, Ji-Won Noh1, Byung-Cheol Lee1
1Department of Clinical Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University.
Chemical & pharmaceutical bulletin
|April 3, 2024
概括
赛可沙尼-A (SSA) 通过减少炎症和改善脂质样本来对抗与肥胖相关的胰岛素抵抗. 这种天然化合物向关键的炎症途径并增强自,为代谢障碍提供治疗潜力.
科学领域:
- 代谢性疾病研究研究.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 肥胖与炎症和自功能受损有关,导致胰岛素抵抗.
- 赛可沙尼-A (SSA) 显示出潜在的抗炎和降脂作用.
研究的目的:
- 研究SSA对肥胖引起的代谢功能障碍的治疗作用.
- 阐明SSA作用背后的分子机制.
主要方法:
- 计算建模用于预测SSA绑定目标.
- 使用高脂肪饮食 (HFD) 诱导肥胖小鼠的动物实验.
- 口服葡萄糖/脂肪耐受性测试,生物化学测试,组织学分析和基因表达分析.
主要成果:
- 在HFD小鼠中,SSA改善了葡萄糖平衡和脂质概况.
- SSA降低了肝脏脂肪的积累和库弗弗细胞的激活.
- SSA调节基因表达,对TNF-α和NF-κB进行下调,同时对FGF21和ATG7.7进行上调.
结论:
- 在肥胖相关的代谢并发症中,SSA显示出治疗潜力.
- SSA的有效性与抑制炎症和增强FGF21和自途径有关.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196


